Novotech Acquires CBR International

Published on: 

Novotech has announced the acquisition of CBR International, a global product development, clinical oversight, and strategic regulatory operations group.

CBR was founded in 2002 as a consultancy company focused on assisting biotechnology and pharma companies navigate FDA requirements from early-stage development through to approval. CBR adds a group of experts to Novotech to provide US and global regulatory, scientific, quality, and clinical development services.


Read more about the acquisition here.